Published in J Affect Disord on December 16, 2010
Blood levels of brain derived neurotrophic factor in women with bipolar disorder and healthy control women. J Affect Disord (2013) 0.79
Brain-derived neurotrophic factor in chronic periodontitis. Mediators Inflamm (2014) 0.78
Shared genetic factors influence risk for bipolar disorder and alcohol use disorders. Eur Psychiatry (2013) 0.76
Dissecting bipolar disorder complexity through epigenomic approach. Mol Psychiatry (2016) 0.75
The bipolar depression electrical treatment trial (BETTER): design, rationale, and objectives of a randomized, sham-controlled trial and data from the pilot study phase. Neural Plast (2015) 0.75
Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet (2011) 4.01
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet (2010) 3.69
Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med (2008) 3.52
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A (2010) 3.13
Decreased in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun (2005) 2.29
Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations. Surgery (2008) 2.26
Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet (2011) 1.94
De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment. Am J Hum Genet (2010) 1.79
HRPT2 gene alterations in ossifying fibroma of the jaws. Oral Oncol (2006) 1.72
A review of psychiatric genetics research in the Brazilian population. Rev Bras Psiquiatr (2009) 1.40
Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.40
The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophr Bull (2007) 1.38
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry (2011) 1.25
Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry (2010) 1.17
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1. J Neurosci (2007) 1.10
Behavioral disorders and low quality of life in children and adolescents with chronic kidney disease. Pediatr Nephrol (2010) 1.08
Population-based and family-based association study of 5'UTR polymorphism of the reelin gene and schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2005) 1.05
Characterization of the tumor suppressor gene WWOX in primary human oral squamous cell carcinomas. Int J Cancer (2006) 1.05
Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr Res (2003) 1.04
Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations. Eur Arch Psychiatry Clin Neurosci (2009) 1.01
Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Res (2004) 1.01
Beta-catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol (2005) 1.00
Increased serum levels of CCL11/eotaxin in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.99
Increased serum levels of brain-derived neurotrophic factor in chronic institutionalized patients with schizophrenia. Neurosci Lett (2008) 0.99
Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med (2005) 0.98
Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison. Psychopharmacology (Berl) (2012) 0.94
Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.94
Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport (2004) 0.94
Papillary thyroid carcinoma with brain metastases: an unusual 10-year-survival case. Thyroid (2010) 0.94
Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome. Clin Endocrinol (Oxf) (2009) 0.93
Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia. Neuroimmunomodulation (2008) 0.91
Thiamine deficiency decreases glutamate uptake in the prefrontal cortex and impairs spatial memory performance in a water maze test. Pharmacol Biochem Behav (2006) 0.90
Brazilian Portuguese version of the Iowa Gambling Task: transcultural adaptation and discriminant validity. Rev Bras Psiquiatr (2008) 0.90
GSTM1 polymorphism and oral squamous cell carcinoma. Oral Oncol (2004) 0.89
Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents? Am J Med Genet B Neuropsychiatr Genet (2007) 0.89
The 5-HTTLPR polymorphism, impulsivity and suicide behavior in euthymic bipolar patients. J Affect Disord (2011) 0.88
Decision-making impairment is related to serotonin transporter promoter polymorphism in a sample of patients with obsessive-compulsive disorder. Behav Brain Res (2008) 0.88
Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex. Eur Neuropsychopharmacol (2009) 0.88
Typical Features of Amelogenesis Imperfecta in Two Patients with Bartter's Syndrome. Nephron Extra (2012) 0.88
Association between GSTT-1 gene deletion and the susceptibility to oral squamous cell carcinoma in cigarette-smoking subjects. Oral Oncol (2005) 0.87
Cortex morphology in first-episode psychosis patients with neurological soft signs. Schizophr Bull (2012) 0.87
Effects of atypical neuroleptics on alertness and visual orienting in stabilized schizophrenic patients: a preliminary study. Int J Neuropsychopharmacol (2004) 0.87
Molecular and immunohistochemical investigation of protein kinase a regulatory subunit type 1A (PRKAR1A) in odontogenic myxomas. Genes Chromosomes Cancer (2005) 0.87
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis. Addict Biol (2011) 0.87
Neuropsychological predictors of response to randomized treatment in obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.87
Specific pattern of attentional changes in impulsive individuals. Cogn Neuropsychiatry (2006) 0.86
Assessment of TP53 mutations in benign and malignant salivary gland neoplasms. PLoS One (2012) 0.86
Age at onset of schizophrenia: interaction between brain-derived neurotrophic factor and dopamine D3 receptor gene variants. Neuroreport (2005) 0.86
PTCH1 isoforms in odontogenic keratocysts. Oral Oncol (2008) 0.86
Neuropsychological assessment of impulsive behavior in abstinent alcohol-dependent subjects. Rev Bras Psiquiatr (2009) 0.86
Cognitive dysfunctions in medicated and unmedicated patients with recent-onset schizophrenia. J Psychiatr Res (2004) 0.86
Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder. Brain (2013) 0.85
Validity of the CAGE questionnaire in schizophrenic patients with alcohol abuse and dependence. Schizophr Res (2005) 0.85
A novel mutation of the SH3BP2 gene in an aggressive case of cherubism. Oral Oncol (2007) 0.85
Molecular alterations in the tumor suppressor gene WWOX in oral leukoplakias. Oral Oncol (2007) 0.84
Diagnostic criteria for autoimmune hepatitis in children: a challenge for pediatric hepatologists. World J Gastroenterol (2012) 0.84
Molecular analysis of the beta-catenin gene in patients with the Mayer-Rokitansky-Küster-Hauser syndrome. J Assist Reprod Genet (2008) 0.84
Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil. Malar J (2014) 0.84
The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder. J Affect Disord (2008) 0.83
Decreased expression of DARPP-32 in oral premalignant and malignant lesions. Anticancer Res (2007) 0.83
Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet (2003) 0.83
Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCD. Clin Neuropharmacol (2011) 0.83
Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease. Clin Dev Immunol (2013) 0.83
Behavioral perturbations after prenatal neurogenesis disturbance in female rat. Neurotox Res (2009) 0.82
Nicotine use in schizophrenia and disinhibition. Psychiatry Res (2004) 0.82
Altered semantic but not phonological verbal fluency in young help-seeking individuals with ultra high risk of psychosis. Schizophr Res (2010) 0.82
Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia. PLoS One (2010) 0.82
NFATc1 and TNFalpha expression in giant cell lesions of the jaws. J Oral Pathol Med (2009) 0.82
Sociodemographic characteristics, clinical factors, and genetic polymorphisms associated with Alzheimer's disease. Int J Geriatr Psychiatry (2012) 0.82
Confirmation of the factorial structure of temperamental autoquestionnaire TEMPS-A in non-clinical young adults and relation to current state of anxiety, depression and to schizotypal traits. J Affect Disord (2011) 0.82
Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers. Addict Biol (2009) 0.82
Clozapine-induced serositis: review of its clinical features, pathophysiology and management strategies. Clin Neuropharmacol (2009) 0.82
Association study of the trinucleotide repeat polymorphism within SMARCA2 and schizophrenia. BMC Genet (2006) 0.81
Novel compound aquaporin 2 mutations in nephrogenic diabetes insipidus. Clinics (Sao Paulo) (2012) 0.81
A dimensional impulsive-aggressive phenotype is associated with the A218C polymorphism of the tryptophan hydroxylase gene: a pilot study in well-characterized impulsive inpatients. Am J Med Genet (2002) 0.81
Evidence of molecular alterations in the tumour suppressor gene WWOX in benign and malignant bone related lesions of the jaws. Oncol Rep (2010) 0.81
Polymorphisms of coding trinucleotide repeats of homeogenes in neurodevelopmental psychiatric disorders. Psychiatr Genet (2008) 0.81
Real world referencing and schizophrenia: are we experiencing the same reality? Neuropsychologia (2010) 0.81
De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry (2010) 0.81
A successful outcome with valproic acid in a case of mania secondary to stroke of the right frontal lobe. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.81
Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease? Parkinsonism Relat Disord (2008) 0.81
Neuroprotective effect on brain injury by neurotoxins from the spider Phoneutria nigriventer. Neurochem Int (2006) 0.81
Urinary chemokines and anti-inflammatory molecules in renal transplanted patients as potential biomarkers of graft function: a prospective study. Int Urol Nephrol (2012) 0.81
Association between the Catechol O-methyltransferase (COMT) Val158met polymorphism and different dimensions of impulsivity. PLoS One (2013) 0.80
Decision-making impairment in obsessive-compulsive disorder as measured by the Iowa Gambling Task. Arq Neuropsiquiatr (2011) 0.80
Exocytotic release of [3H]-acetylcholine by ouabain involves intracellular Ca2+ stores in rat brain cortical slices. Cell Mol Neurobiol (2003) 0.80
Cognitive remediation therapy (CRT) benefits more to patients with schizophrenia with low initial memory performances. Disabil Rehabil (2014) 0.80